|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 78.40 USD | -0.13% |
|
-0.56% | +3.21% |
| 07-07 | RBC Capital Adjusts PTC Therapeutics Price Target to $85 From $82, Maintains Sector Perform Rating | MT |
| 06-28 | PTC Therapeutics, Inc.(NasdaqGS:PTCT) added to Russell 2000 Value-Defensive Index | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PTC THERAPEUTICS, INC. | Other Pharmaceuticals | -0.13% | -0.56% | +3.21% | +69.00% | +86.31% | 6.5B |  |  | |
- Stock Market
- Stocks
- PTCT Stock
- Charts PTC Therapeutics, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
